Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 51 entries
Sorted by: Best Match Show Resources per page
Significant FDA approvals in 1990.

American family physician

Rheinstein PH.
PMID: 2042556
Am Fam Physician. 1991 Jun;43(6):2257-8.

No abstract available.

Cite
Rheinstein PH. Significant FDA approvals in 1990. Am Fam Physician. 1991;43(6):2257-8
Rheinstein, P. H. (1991). Significant FDA approvals in 1990. American family physician, 43(6), 2257-8.
Rheinstein, P H. "Significant FDA approvals in 1990." American family physician vol. 43,6 (1991): 2257-8.
Rheinstein PH. Significant FDA approvals in 1990. Am Fam Physician. 1991 Jun;43(6):2257-8. PMID: 2042556.
Copy Download .nbib Format: NLM
[New ways of electrocardiography].

Das Deutsche Gesundheitswesen

REINSTEIN H.
PMID: 13067703
Dtsch Gesundheitsw. 1953 Jan 29;8(5):142-5.

No abstract available.

Cite
REINSTEIN H. Neue Wege der Elektrokardiographie. [New ways of electrocardiography]. Dtsch Gesundheitsw. 1953;8(5):142-5
REINSTEIN, H. (1953). Neue Wege der Elektrokardiographie. [New ways of electrocardiography]. Das Deutsche Gesundheitswesen, 8(5), 142-5.
REINSTEIN, H. "Neue Wege der Elektrokardiographie." [New ways of electrocardiography]. Das Deutsche Gesundheitswesen vol. 8,5 (1953): 142-5.
REINSTEIN H. Neue Wege der Elektrokardiographie. [New ways of electrocardiography]. Dtsch Gesundheitsw. 1953 Jan 29;8(5):142-5. Undetermined. PMID: 13067703.
Copy Download .nbib Format: NLM
Activation of Phospholipase A by Plant Defense Elicitors.

Plant physiology

Chandra S, Heinstein PF, Low PS.
PMID: 12226235
Plant Physiol. 1996 Mar;110(3):979-986. doi: 10.1104/pp.110.3.979.

Participation of phospholipase A (PLase A) in plant signal transduction has been documented for auxin stimulation of growth but not for elicitation of any plant defense response. In this paper, we report two independent assays for monitoring PLase A...

Cite
Chandra S, Heinstein PF, Low PS. Activation of Phospholipase A by Plant Defense Elicitors. Plant Physiol. 1996;110(3):979-986doi: 10.1104/pp.110.3.979.
Chandra, S., Heinstein, P. F., & Low, P. S. (1996). Activation of Phospholipase A by Plant Defense Elicitors. Plant physiology, 110(3), 979-986. https://doi.org/10.1104/pp.110.3.979
Chandra, S., et al. "Activation of Phospholipase A by Plant Defense Elicitors." Plant physiology vol. 110,3 (1996): 979-986. doi: https://doi.org/10.1104/pp.110.3.979
Chandra S, Heinstein PF, Low PS. Activation of Phospholipase A by Plant Defense Elicitors. Plant Physiol. 1996 Mar;110(3):979-986. doi: 10.1104/pp.110.3.979. PMID: 12226235; PMCID: PMC157798.
Copy Download .nbib Format: NLM
[Current ECG problems].

Zeitschrift fur arztliche Fortbildung

REINSTEIN H.
PMID: 13423404
Z Arztl Fortbild (Jena). 1957 Feb 01;51(3):106-11.

No abstract available.

Cite
REINSTEIN H. Aktuelle Fragen der Elektrokardiographie. [Current ECG problems]. Z Arztl Fortbild (Jena). 1957;51(3):106-11
REINSTEIN, H. (1957). Aktuelle Fragen der Elektrokardiographie. [Current ECG problems]. Zeitschrift fur arztliche Fortbildung, 51(3), 106-11.
REINSTEIN, H. "Aktuelle Fragen der Elektrokardiographie." [Current ECG problems]. Zeitschrift fur arztliche Fortbildung vol. 51,3 (1957): 106-11.
REINSTEIN H. Aktuelle Fragen der Elektrokardiographie. [Current ECG problems]. Z Arztl Fortbild (Jena). 1957 Feb 01;51(3):106-11. German. PMID: 13423404.
Copy Download .nbib Format: NLM
FBXW7, L1CAM, and TGM2 in endometrial cancer.

Cancer

Lehrer S, Rheinstein PH.
PMID: 34324708
Cancer. 2021 Nov 01;127(21):4103-4104. doi: 10.1002/cncr.33782. Epub 2021 Jul 29.

No abstract available.

Cite
Lehrer S, Rheinstein PH. FBXW7, L1CAM, and TGM2 in endometrial cancer. Cancer. 2021;127(21):4103-4104doi: 10.1002/cncr.33782.
Lehrer, S., & Rheinstein, P. H. (2021). FBXW7, L1CAM, and TGM2 in endometrial cancer. Cancer, 127(21), 4103-4104. https://doi.org/10.1002/cncr.33782
Lehrer, Steven, and Rheinstein, Peter H. "FBXW7, L1CAM, and TGM2 in endometrial cancer." Cancer vol. 127,21 (2021): 4103-4104. doi: https://doi.org/10.1002/cncr.33782
Lehrer S, Rheinstein PH. FBXW7, L1CAM, and TGM2 in endometrial cancer. Cancer. 2021 Nov 01;127(21):4103-4104. doi: 10.1002/cncr.33782. Epub 2021 Jul 29. PMID: 34324708.
Copy Download .nbib Format: NLM
Druggable genetic targets in endometrial cancer.

Cancer treatment and research communications

Lehrer S, Rheinstein PH.
PMID: 34933203
Cancer Treat Res Commun. 2021 Dec 17;30:100502. doi: 10.1016/j.ctarc.2021.100502. Epub 2021 Dec 17.

BACKGROUND: FBXW7 is frequently somatically mutated in grade 3 endometrioid endometrial cancers (G3EECs) and serous endometrial cancers (SECs), high-risk cancers associated with poor prognosis. CRISPR-edited cell lines identified the proteomic and phosphoproteomic effects of FBXW7 mutation in 3 high-risk...

Cite
Lehrer S, Rheinstein PH. Druggable genetic targets in endometrial cancer. Cancer Treat Res Commun. 2021;30:100502doi: 10.1016/j.ctarc.2021.100502.
Lehrer, S., & Rheinstein, P. H. (2021). Druggable genetic targets in endometrial cancer. Cancer treatment and research communications, 30100502. https://doi.org/10.1016/j.ctarc.2021.100502
Lehrer, Steven, and Rheinstein, Peter H. "Druggable genetic targets in endometrial cancer." Cancer treatment and research communications vol. 30 (2021): 100502. doi: https://doi.org/10.1016/j.ctarc.2021.100502
Lehrer S, Rheinstein PH. Druggable genetic targets in endometrial cancer. Cancer Treat Res Commun. 2021 Dec 17;30:100502. doi: 10.1016/j.ctarc.2021.100502. Epub 2021 Dec 17. PMID: 34933203.
Copy Download .nbib Format: NLM
Druggable genetic targets in endometrial cancer.

Cancer treatment and research communications

Lehrer S, Rheinstein PH.
PMID: 34933203
Cancer Treat Res Commun. 2021 Dec 17;30:100502. doi: 10.1016/j.ctarc.2021.100502. Epub 2021 Dec 17.

BACKGROUND: FBXW7 is frequently somatically mutated in grade 3 endometrioid endometrial cancers (G3EECs) and serous endometrial cancers (SECs), high-risk cancers associated with poor prognosis. CRISPR-edited cell lines identified the proteomic and phosphoproteomic effects of FBXW7 mutation in 3 high-risk...

Cite
Lehrer S, Rheinstein PH. Druggable genetic targets in endometrial cancer. Cancer Treat Res Commun. 2021;30:100502doi: 10.1016/j.ctarc.2021.100502.
Lehrer, S., & Rheinstein, P. H. (2021). Druggable genetic targets in endometrial cancer. Cancer treatment and research communications, 30100502. https://doi.org/10.1016/j.ctarc.2021.100502
Lehrer, Steven, and Rheinstein, Peter H. "Druggable genetic targets in endometrial cancer." Cancer treatment and research communications vol. 30 (2021): 100502. doi: https://doi.org/10.1016/j.ctarc.2021.100502
Lehrer S, Rheinstein PH. Druggable genetic targets in endometrial cancer. Cancer Treat Res Commun. 2021 Dec 17;30:100502. doi: 10.1016/j.ctarc.2021.100502. Epub 2021 Dec 17. PMID: 34933203.
Copy Download .nbib Format: NLM
FUNCTIONAL DIFFERENCES OF BILATERAL TRANSFEMORAL AMPUTEES USING FULL-LENGTH AND STUBBY-LENGTH PROSTHESES.

Technology and innovation

Carroll MK, Carroll K, Rheinstein J, Highsmith MJ.
PMID: 31788157
Technol Innov. 2018 Nov;20(1):75-83. doi: 10.21300/20.1-2.2018.75.

Many unilateral amputations are followed by a contralateral amputation within three years, sometimes presenting as bilateral transfemoral amputations. Bilateral transfemoral amputees that successfully use prostheses are an understudied patient population. This study establishes reference values for this population in...

Cite
Carroll MK, Carroll K, Rheinstein J, et al. FUNCTIONAL DIFFERENCES OF BILATERAL TRANSFEMORAL AMPUTEES USING FULL-LENGTH AND STUBBY-LENGTH PROSTHESES. Technol Innov. 2018;20(1):75-83doi: 10.21300/20.1-2.2018.75.
Carroll, M. K., Carroll, K., Rheinstein, J., & Highsmith, M. J. (2018). FUNCTIONAL DIFFERENCES OF BILATERAL TRANSFEMORAL AMPUTEES USING FULL-LENGTH AND STUBBY-LENGTH PROSTHESES. Technology and innovation, 20(1), 75-83. https://doi.org/10.21300/20.1-2.2018.75
Carroll, Michael K, et al. "FUNCTIONAL DIFFERENCES OF BILATERAL TRANSFEMORAL AMPUTEES USING FULL-LENGTH AND STUBBY-LENGTH PROSTHESES." Technology and innovation vol. 20,1 (2018): 75-83. doi: https://doi.org/10.21300/20.1-2.2018.75
Carroll MK, Carroll K, Rheinstein J, Highsmith MJ. FUNCTIONAL DIFFERENCES OF BILATERAL TRANSFEMORAL AMPUTEES USING FULL-LENGTH AND STUBBY-LENGTH PROSTHESES. Technol Innov. 2018 Nov;20(1):75-83. doi: 10.21300/20.1-2.2018.75. PMID: 31788157; PMCID: PMC6884005.
Copy Download .nbib Format: NLM
Druggable genetic targets in endometrial cancer.

Cancer treatment and research communications

Lehrer S, Rheinstein PH.
PMID: 34933203
Cancer Treat Res Commun. 2021 Dec 17;30:100502. doi: 10.1016/j.ctarc.2021.100502. Epub 2021 Dec 17.

BACKGROUND: FBXW7 is frequently somatically mutated in grade 3 endometrioid endometrial cancers (G3EECs) and serous endometrial cancers (SECs), high-risk cancers associated with poor prognosis. CRISPR-edited cell lines identified the proteomic and phosphoproteomic effects of FBXW7 mutation in 3 high-risk...

Cite
Lehrer S, Rheinstein PH. Druggable genetic targets in endometrial cancer. Cancer Treat Res Commun. 2021;30:100502doi: 10.1016/j.ctarc.2021.100502.
Lehrer, S., & Rheinstein, P. H. (2021). Druggable genetic targets in endometrial cancer. Cancer treatment and research communications, 30100502. https://doi.org/10.1016/j.ctarc.2021.100502
Lehrer, Steven, and Rheinstein, Peter H. "Druggable genetic targets in endometrial cancer." Cancer treatment and research communications vol. 30 (2021): 100502. doi: https://doi.org/10.1016/j.ctarc.2021.100502
Lehrer S, Rheinstein PH. Druggable genetic targets in endometrial cancer. Cancer Treat Res Commun. 2021 Dec 17;30:100502. doi: 10.1016/j.ctarc.2021.100502. Epub 2021 Dec 17. PMID: 34933203.
Copy Download .nbib Format: NLM
Alzheimer's Disease Susceptibility Genes in Malignant Breast Tumors.

Cancer translational medicine

Lehrer S, Rheinstein PH.
PMID: 31453369
Cancer Transl Med. 2019 Apr-Jun;5(2):42-46. doi: 10.4103/2395-3977.261826. Epub 2019 Jun 28.

BACKGROUND: Cognitive problems have been reported in breast cancer patients after chemotherapy. A small group of older breast cancer survivors carrying the APOE4 gene, receiving chemotherapy, was at increased risk of long-term impairment of brain function. We have analyzed...

Cite
Lehrer S, Rheinstein PH. Alzheimer's Disease Susceptibility Genes in Malignant Breast Tumors. Cancer Transl Med. 2019;5(2):42-46doi: 10.4103/2395-3977.261826.
Lehrer, S., & Rheinstein, P. H. (2019). Alzheimer's Disease Susceptibility Genes in Malignant Breast Tumors. Cancer translational medicine, 5(2), 42-46. https://doi.org/10.4103/2395-3977.261826
Lehrer, Steven, and Rheinstein, Peter H. "Alzheimer's Disease Susceptibility Genes in Malignant Breast Tumors." Cancer translational medicine vol. 5,2 (2019): 42-46. doi: https://doi.org/10.4103/2395-3977.261826
Lehrer S, Rheinstein PH. Alzheimer's Disease Susceptibility Genes in Malignant Breast Tumors. Cancer Transl Med. 2019 Apr-Jun;5(2):42-46. doi: 10.4103/2395-3977.261826. Epub 2019 Jun 28. PMID: 31453369; PMCID: PMC6709700.
Copy Download .nbib Format: NLM
Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma.

Glioma (Mumbai, India)

Lehrer S, Rheinstein PH, Rosenzweig KE.
PMID: 30272052
Glioma. 2018 Jul-Aug;1(4):132-135. doi: 10.4103/glioma.glioma_17_18. Epub 2018 Aug 30.

BACKGROUND: Venous thromboembolism is a common complication in patients with glioma. The clotting factor von Willebrand factor (VWF) is a highly adhesive procoagulant molecule that mediates platelet adhesion to endothelial and subendothelial surfaces. In the current analysis, we examined...

Cite
Lehrer S, Rheinstein PH, Rosenzweig KE. Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma. Glioma. 2018;1(4):132-135doi: 10.4103/glioma.glioma_17_18.
Lehrer, S., Rheinstein, P. H., & Rosenzweig, K. E. (2018). Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma. Glioma (Mumbai, India), 1(4), 132-135. https://doi.org/10.4103/glioma.glioma_17_18
Lehrer, Steven, et al. "Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma." Glioma (Mumbai, India) vol. 1,4 (2018): 132-135. doi: https://doi.org/10.4103/glioma.glioma_17_18
Lehrer S, Rheinstein PH, Rosenzweig KE. Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma. Glioma. 2018 Jul-Aug;1(4):132-135. doi: 10.4103/glioma.glioma_17_18. Epub 2018 Aug 30. PMID: 30272052; PMCID: PMC6157623.
Copy Download .nbib Format: NLM
[A steady source of power for the electrocardiograph].

Das Deutsche Gesundheitswesen

REINSTEIN H.
PMID: 15435139
Dtsch Gesundheitsw. 1950 Jul 06;5(27):860.

No abstract available.

Cite
REINSTEIN H. Uber eine Dauerstromversorgung des Elektrokardiographen. [A steady source of power for the electrocardiograph]. Dtsch Gesundheitsw. 1950;5(27):860
REINSTEIN, H. (1950). Uber eine Dauerstromversorgung des Elektrokardiographen. [A steady source of power for the electrocardiograph]. Das Deutsche Gesundheitswesen, 5(27), 860.
REINSTEIN, H. "Uber eine Dauerstromversorgung des Elektrokardiographen." [A steady source of power for the electrocardiograph]. Das Deutsche Gesundheitswesen vol. 5,27 (1950): 860.
REINSTEIN H. Uber eine Dauerstromversorgung des Elektrokardiographen. [A steady source of power for the electrocardiograph]. Dtsch Gesundheitsw. 1950 Jul 06;5(27):860. Undetermined. PMID: 15435139.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 51 entries